CareDx, Inc. (CDNA)
SERVICES-MEDICAL LABORATORIES
CareDx, Inc. (CDNA) is listed on Nasdaq, where it has traded since July 17, 2014.
- Listed On
- Nasdaq
- Listed Since
- July 17, 2014
- Employees
- 765
- Market Cap
- $3.3B
About CareDx, Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 220 institutions reported holding CDNA, with 52.8 million shares worth $1.5 billion in aggregate. The largest reported holder was BlackRock, with 4.8 million shares worth $137.2 million. Of the 5 largest holders listed below, 2 added shares and 3 reduced their positions during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 4,814,709 | $137M | Added 6.47% |
| Vanguard | 3,619,799 | $103M | Added 5.59% |
| State Street | 2,468,858 | $70M | Reduced 10.56% |
| Deerfield Management Company, | 1,997,618 | $57M | Reduced 8.83% |
| ARK Invest | 1,953,531 | $56M | Reduced 12.3% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is CDNA?
CareDx, Inc. (CDNA) is listed on Nasdaq, where it has traded since July 17, 2014.
Who are the largest institutional holders of CDNA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of CDNA were BlackRock, Vanguard and State Street.
How many institutions own CDNA?
220 institutions reported a position in CDNA for the quarter ended June 30, 2026, worth $1.5 billion in total.
Did institutions buy or sell CDNA last quarter?
Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for CDNA.
Every reported institutional holder, plus insider and congressional trades in CDNA, on SentiSense.